CalciMedica
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
505 Coast Blvd S Ste 307, La Jolla, Cali...Phone Number
(858) 952-5500Website
www.calcimedica.comRevenue
<$5 MillionStock Symbol
CALCIndustry
About CalciMedica
CalciMedica is a clinical-stage biopharmaceutical company focused on advancing CRAC channel inhibitors for the treatment of pulmonary hypertension and acute pancreatitis. The company is developing two investigational treatments: intravenous Auxora for hospital-based use and oral CM5480 for chronic treatment. Their target clients include healthcare providers and patients suffering from these conditions, addressing significant therapeutic gaps in both areas. CalciMedica aims to improve patient outcomes by inhibiting persistent CRAC channel activity associated with disease progression.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CALCShow moreCalciMedica Org Chart
Compare Similar Companies to CalciMedica
Compare insights from companies similar to CalciMedica, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CalciMedica Tech Stack
A closer look at the technologies used by CalciMedica
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding CalciMedica
Sign Up For FreeTo access detailed company insights
CalciMedica is a clinical-stage biopharmaceutical company focused on advancing CRAC channel inhibitors for the treatment of pulmonary hypertension and acute pancreatitis. The company is developing two investigational treatments: intravenous Auxora for hospital-based use and oral CM5480 for chronic treatment. Their target clients include healthcare... Read More